For healthcare professionals only

News Shortcuts from other journals

The pros and cons of new treatments for type 2 diabetes

BMJ 2007; 335 doi: (Published 19 July 2007) Cite this as: BMJ 2007;335:121

Incretins are gut peptides that help regulate glucose metabolism by augmenting the release of insulin. Since 2005, the US Food and Drug Administration has licensed two new classes of drug exploiting this pathway for treating adults with type 2 diabetes …

View Full Text

Log in

Log in through your institution


* For online subscription